EMN · XBRL financial data
Eastman Chemical financial statements, every fiscal year
The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (EMN's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 8,473 | 10,476 | 10,580 | 9,210 | 9,382 | 8,752 |
| Cost of goods and services sold | 6,498 | 7,976 | 8,443 | 7,149 | 7,092 | 6,908 |
| Gross profit | 1,975 | 2,500 | 2,137 | 2,061 | 2,290 | 1,844 |
| Research and development | 226 | 254 | 264 | 239 | 250 | 255 |
| Selling, general and administrative | 654 | 795 | 726 | 727 | 736 | 658 |
| Other income (expense) | (7) | 11 | 3 | (37) | (36) | (74) |
| Income tax expense (benefit) | 41 | 215 | 181 | 191 | 170 | 93 |
| Net income (loss) | 478 | 857 | 793 | 894 | 905 | 474 |
| Earnings per share, basic USD per share | 3.53 | 6.35 | 6.42 | 7.54 | 7.75 | 4.14 |
| Earnings per share, diluted USD per share | 3.50 | 6.25 | 6.35 | 7.49 | 7.67 | 4.10 |
| Weighted average shares, basic millions of shares | 136 | 135 | 124 | 119 | 117 | 115 |
| Weighted average shares, diluted millions of shares | 137 | 137 | 125 | 119 | 118 | 116 |
Balance sheet
CSVFiscal years (EMN's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 564 | 459 | 493 | 548 | 837 | 566 |
| Accounts receivable | 1,033 | 1,091 | 957 | 826 | 791 | 737 |
| Inventory | 1,379 | 1,504 | 1,894 | 1,683 | 1,988 | 1,980 |
| Total current assets | 3,541 | 4,646 | 3,778 | 3,481 | 4,101 | 3,645 |
| Property and equipment, net | 5,549 | 4,996 | 5,160 | 5,548 | 5,615 | 5,731 |
| Right-of-use asset | 176 | 216 | — | — | — | — |
| Goodwill | 4,465 | 3,641 | 3,664 | 3,646 | 3,632 | 3,665 |
| Total assets | 16,083 | 15,519 | 14,667 | 14,633 | 15,213 | 14,859 |
| Commercial paper | — | 0 | 326 | — | — | — |
| Total current liabilities | 2,038 | 2,971 | 3,251 | 2,576 | 2,708 | 2,652 |
| Long-term debt | 5,269 | 4,412 | 4,025 | 4,305 | 4,567 | 4,201 |
| Total liabilities | 9,975 | 9,731 | 9,431 | 9,103 | 9,361 | 8,822 |
| Retained earnings | 8,080 | 8,557 | 8,973 | 9,490 | 10,013 | 10,105 |
| Total stockholders' equity | 6,023 | 5,704 | 5,153 | 5,458 | 5,779 | 5,961 |
| Total liabilities and equity | 16,083 | 15,519 | 14,667 | 14,633 | 15,213 | 14,859 |
| Common shares outstanding (cover page) millions of shares | 136 | 129 | 119 | 117 | 115 | 114 |
Cash flows
CSVFiscal years (EMN's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 478 | 857 | 793 | 894 | 905 | 474 |
| Depreciation and amortization | 574 | 538 | 477 | 498 | 509 | 513 |
| Net cash from operating activities | 1,455 | 1,619 | 975 | 1,374 | 1,287 | 970 |
| Purchases of property and equipment | 383 | 555 | 611 | 828 | 599 | 546 |
| Net cash from investing activities | (394) | (29) | 392 | (432) | (534) | (462) |
| Share repurchases | — | 900 | — | — | — | — |
| Dividends paid | 358 | 375 | 381 | 376 | 379 | 381 |
| Proceeds from long-term debt | 249 | 0 | 500 | 796 | 1,237 | 246 |
| Repayments of long-term debt | 435 | 300 | 750 | 808 | 1,039 | 550 |
| Net cash from financing activities | (704) | (1,690) | (1,321) | (888) | (454) | (797) |
| Net change in cash | 360 | (105) | 34 | 55 | 289 | (271) |
Compare with peers
SIC 2821 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 2821 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Eastman Chemical | 768 | 2,385 | 290* | 114.4M | 10-QSep 30, 2026 |
| Albemarle | 1,632 | 1,743 | 710* | 118.0M | 10-QJun 30, 2026 |
| Celanese | 1,362 | 2,556 | 538* | 109.8M | 10-QSep 30, 2026 |
| DuPont de Nemours | 1,652 | 1,868 | 410* | 132.5M | 10-QSep 30, 2026 |
| Sealed Air | 344 | 1,401* | 294* | 147.4M | 10-KDec 31, 2025 |
| Hexcel | 78 | 496 | 74* | 75.7M | 10-QSep 30, 2026 |
| Dow | 4,142 | 11,267 | not reported | 723.9M | 10-QSep 30, 2026 |
| EIDP | 2,365 | 6,379 | not reported | 667.2M | 10-QJun 30, 2026 |
| Avient | not reported | 891 | not reported | 91.7M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.